Effect of Calcium and Vitamin D Supplementation With and Without Collagen Peptides on Volumetric and Areal Bone Mineral Density, Bone Geometry and Bone Turnover in Postmenopausal Women With Osteopenia.


Collagen peptides (CPs) have been shown to potentially have a role as a treatment option in osteopenia. In the present randomized prospective study, we examined the effect of calcium, vitamin D with and without CPs supplementation on changes in volumetric bone mineral density (vBMD) and bone geometry assessed by peripheral quantitative computed tomography at the tibia, areal bone mineral density (aBMD) assessed by dual-energy X-ray absorptiometry at the lumbar spine and the hip and bone turnover markers over 12-mo. Fifty-one postmenopausal women with osteopenia were allocated to Group A who received orally 5 g CPs, 500 mg calcium and 400 IU vitamin D3 and Group B who received the same dose of calcium and vitamin D3 per day. The primary endpoint was the change of trabecular bone mineral content (BMC) and vBMD after 12-mo supplementation in Groups A and B. At the trabecular site (4% of the tibia length), Group A had a significant increase of total BMC by 1.96 +/- 2.41% and cross-sectional area by 2.58 +/- 3.91%, trabecular BMC by 5.24 +/- 6.48%, cross-sectional area by 2.58 +/- 3.91% and vBMD by 2.54 +/- 3.43% and a higher % change of these parameters at 12 mo in comparison to Group B (p < 0.01, p=0.04, p < 0.01, p=0.04, p=0.02, respectively). At the cortical site (38% of the tibia length), total and cortical vBMD increased by 1.01 +/- 2.57% and 0.67 +/- 1.71%. Furthermore, the mean aBMD at the spine was higher (p=0.01), while bone markers decreased in Group A compared to Group B. The present study shows improvement of trabecular and cortical parameters as assessed by peripheral quantitative computed tomography at the tibia, prevention of aBMD decline and decrease of bone turnover after 12-mo supplementation with calcium, vitamin D with CPs.

Autor: Lampropoulou-Adamidou K, Karlafti E, Argyrou C, Makris K, Trovas G, Dontas IA, Tournis S, Triantafyllopoulos IK

Organisation: Laboratory for Research of the Musculoskeletal System 'Th. Garofalidis', Medical School, National and Kapodistrian University of Athens, KAT General Hospital of Athens, Athens, Greece. Electronic address: kilampropoulou@gmail.com.

Jahr: 2021

GID: 5732

Erstellt am: 20.06.2022

Das Urteil unserer Kunden: Hervorragend


4,7 von 5 Sternen basierend auf 868 Bewertungen

TÜV zertifiziert

Wir sind vom TÜV zertifizierter Hersteller für Medizinprodukte.

Made in Germany

Die Entwicklung und Herstellung findet nur in Deutschland statt.

Bewährte Qualität

10 Jahre Servicegarantie & mehr als 35 Jahre Erfahrung im Firmenverbund.


Über 2000 wissenschaftliche Publikationen zu unseren Produkten.

Weltweit Tätig

Mit unseren Vertriebspartnern international tätig.

Fangen Sie an zu tippen, um die gesuchten Beiträge zu sehen.